IMPROVING REGULATORY TRANSPARENCY FOR NEW MEDICAL THERAPIES ACT

Amendments

Enact (H.R. 639), S7494 [26OC], H8212 [16NO]

Bills and resolutions

Enact (see S. 481), S982 [12FE]

Cost Estimates

Provisions (H.R. 639): CBO, H1641 [16MR]

Letters

Provisions: Representative Goodlatte, Committee on the Judiciary (House), H1640 [16MR]

——— Representative Upton, Committee on Energy and Commerce (House), H1640 [16MR]

Remarks in House

Enact (H.R. 639), H1638–H1641 [16MR]

——— Senate amendment, H8212, H8213 [16NO]

Remarks in Senate

Enact (H.R. 639), S7495 [26OC]

Reports filed

Provisions: Committee on Energy and Commerce (House) (H.R. 639) (H. Rept. 114–41), H1660 [16MR]

——— Committee on Health, Education, Labor, and Pensions (Senate) (S. 481), S7101 [1OC]

Texts of

H.R. 639, provisions, H1638 [16MR], H8212 [16NO]